ID 100222322 v. BP Exploration & Prodn, I

CourtCourt of Appeals for the Fifth Circuit
DecidedMay 9, 2019
Docket18-30241
StatusUnpublished

This text of ID 100222322 v. BP Exploration & Prodn, I (ID 100222322 v. BP Exploration & Prodn, I) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fifth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ID 100222322 v. BP Exploration & Prodn, I, (5th Cir. 2019).

Opinion

IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT United States Court of Appeals Fifth Circuit

FILED No. 18-30241 May 9, 2019 Lyle W. Cayce CLAIMANT ID 100222322, Clerk

Requesting Party - Appellant

v.

BP EXPLORATION & PRODUCTION, INCORPORATED; BP AMERICA PRODUCTION COMPANY; BP, P.L.C.,

Objecting Parties - Appellees

Appeal from the United States District Court for the Eastern District of Louisiana USDC No. 2:18-CV-37

Before HIGGINBOTHAM, JONES, and COSTA, Circuit Judges. PER CURIAM:* Claimant, Michael Dattoli, PLC, seeks compensation under the Deepwater Horizon court-supervised settlement program. It has been rebuffed at each step of the claim process because it cannot show that it was in existence more than eighteen months before the oil spill—leading the Claims Administrator to classify its claim as a Start-Up Business claim. The district

* Pursuant to 5TH CIR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5TH CIR. R. 47.5.4. No. 18-30241 court granted discretionary review and agreed that the claim was properly addressed through the Settlement’s Start-Up Business program. Finding no error in the district court’s decision, we affirm. I Sarasota Health Group LLC was a medical practice founded in 2000. It was owned by two medical doctors, Dr. Michael Dattoli and Dr. Richard Sorace, and one lawyer, Donald Kaltenbach. Beginning in 2006, SHG began operating under the name “Dattoli Cancer Center and Brachytherapy Institute.” In March of 2009, following a dispute between the owners, Claimant “Michael Dattoli, PLC”—solely owned by Dr. Dattoli—purchased all of SHG’s assets through an asset purchase agreement. 1 Claimant ultimately operated a business in the same location and with the same employees, patients, services, and operating name as SHG. SHG continued to exist, as well. At a minimum, SHG continued to collect old accounts receivable; there is also evidence that it had over $100,000 in assets as of 2012, a $400 decrease from 2011. The parties disagree as to whether Claimant also assumed all of SHG’s liabilities through the asset purchase agreement, or whether it only assumed certain liabilities specified in the agreement. 2 In June 2013, Claimant filed a Business Economic Loss claim with the court-supervised settlement program. The Claims Administrator ultimately reclassified the claim to fall under the Start-Up Business Economic Loss program, which applies to claimants “with less than eighteen months of

1 Shortly before this time, Dr. Sorace sold his shares of ownership in SHG to Dr. Dattoli, such that SHG was owned by Dattoli and Kaltenbach at the time of the sale. 2 The asset purchase agreement provided for Claimant to assume liabilities “to include

accounts payable from the normal operation of the business, the equipment lease with Synovus Bank and the employment agreement with Richard A. Sorace, MD . . . free and clear of any and all other liabilities, accrued or contingent.” Claimant argues, however, that this in fact encompassed all of SHG’s liabilities. As we will explain, the resolution of this disagreement ultimately does not affect our decision. 2 No. 18-30241 operating history at the time of the [spill].” The parties agree that the Start- Up Business Economic Loss program applies a more stringent causation test than the standard Business Economic Loss program. Applying this more stringent standard, and excluding SHG’s financial information, the Claims Administrator denied the claim for failure to demonstrate causation. 3 The Appeal Panel reached the same conclusion. The district court granted discretionary review and affirmed the Appeal Panel, concluding that although SHG operated an oncology practice at the same location and with the same staff as Claimant’s current practice, “those two legal entities have differing ownership makeups, and further, the respective owners have no familial relationship.” Therefore, “[u]nder these circumstances, the Settlement Program was correct to decline to use the financials of the prior legal entity when evaluating the claim of the later legal entity.” Claimant brought this appeal. II When reviewing the district court’s denial of discretionary review for abuse of discretion, “the standard of review is effectively de novo . . . [when] the district court was presented with purely legal questions of contract interpretation.” 4 We have recently held that interpretive issues are similarly reviewed de novo when the district court granted discretionary review and affirmed the Appeal Panel. 5 We have not yet resolved what standard of review applies to the district court’s factual determinations when the district court grants discretionary

3 The Claims Administrator also denied re-review and reconsideration. 4 See In re Deepwater Horizon, 785 F.3d 1003, 1011 (5th Cir. 2015). 5 See Claimant ID 100081155 v. BP Expl. & Pod., Inc., 920 F.3d 925, 928 (5th Cir.

2019). 3 No. 18-30241 review and addresses the merits of a claim. 6 Ultimately, we need not decide this issue here, because this case does not hinge on factual findings made by the district court. 7 The only point of genuine factual contention between the parties on this appeal appears to be whether the asset purchase agreement transferred all or only some liabilities to Claimant from SHG. Even taking the facts as Claimant has presented them—that the asset purchase agreement involved a complete transfer of liabilities from SHG to Claimant, in addition to a complete transfer of assets—there was no error in classifying the claim as a Start-Up Business claim. III Claimant does not argue on appeal that the Claims Administrator misapplied the causation requirement under the Start-Up framework. The sole issue is whether the district court erred in holding that the claim was properly classified as a Start-Up Business claim. It did not. A Two of our previous court-supervised settlement cases guide us in this inquiry. While both opinions were unpublished and therefore nonprecedential, we agree with their reasoning and conclude that the district court did not err in concluding that the Start-Up Business Program framework applied to Claimant. In BP Exploration & Production, Inc. v. Claimant ID 100169608 (Adams Produce), a food distributor, Adams Produce Company, Inc., approved a liquidation plan and reached an asset transfer agreement with a separate entity, Adams Produce Company, LLC, after the Deepwater Horizon spill. 8 The

6 See BP Expl. & Prod., Inc. v. Claimant ID 100169608 (Adams Produce), 682 F. App’x 256, 259 n.3 (5th Cir. 2017) (per curiam) (discussing, though not deciding, the proper standard of review). 7 See Claimant ID 100081155, 920 F.3d at 928 (applying the same reasoning). 8 Adams Produce, 682 F. App’x at 257.

4 No. 18-30241 asset transfer agreement transferred only certain assets and liabilities; the LLC continued to operate “Adams Produce,” which had previously been operated by the corporation. 9 The Appeal Panel allowed the LLC to file a claim based on the continued operation of the “Adams Produce” business enterprise—even though the LLC had not operated prior to the oil spill. 10 The district court reversed, reasoning that the LLC could not rely on the corporation’s pre-spill operation of the underlying “Adams Produce” business because the transaction had involved a transfer of assets, not merely a sale of the corporation’s stock or a change in corporate organization.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

ID 100009540 v. BP Exploration & Production, Inc.
680 F. App'x 263 (Fifth Circuit, 2017)
BP Exploration & Production, Inc. v. Id 100169608
682 F. App'x 256 (Fifth Circuit, 2017)
ID 100081155 v. BP Exploration & Prodn, I
920 F.3d 925 (Fifth Circuit, 2019)

Cite This Page — Counsel Stack

Bluebook (online)
ID 100222322 v. BP Exploration & Prodn, I, Counsel Stack Legal Research, https://law.counselstack.com/opinion/id-100222322-v-bp-exploration-prodn-i-ca5-2019.